Asaf Danziger - Net Worth and Insider Trading

Asaf Danziger Net Worth

The estimated net worth of Asaf Danziger is at least $225,444 dollars as of 2025-04-15. Asaf Danziger is the CEO of NovoCure Ltd and owns about 13,622 shares of NovoCure Ltd (NVCR) stock worth over $225,444. Details can be seen in Asaf Danziger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Asaf Danziger has not made any transactions after 2023-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Asaf Danziger

To

Asaf Danziger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Asaf Danziger owns 1 companies in total, including NovoCure Ltd (NVCR) .

Click here to see the complete history of Asaf Danziger’s form 4 insider trades.

Insider Ownership Summary of Asaf Danziger

Ticker Comapny Transaction Date Type of Owner
NVCR NovoCure Ltd 2023-01-05 director & Chief Executive Officer

Asaf Danziger Latest Holdings Summary

Asaf Danziger currently owns a total of 1 stock. Asaf Danziger owns 13,622 shares of NovoCure Ltd (NVCR) as of January 5, 2023, with a value of $225,444.

Latest Holdings of Asaf Danziger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVCR NovoCure Ltd 2023-01-05 13,622 16.55 225,444

Holding Weightings of Asaf Danziger


Asaf Danziger Form 4 Trading Tracker

According to the SEC Form 4 filings, Asaf Danziger has made a total of 5 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in NovoCure Ltd is the sale of 212,500 shares on January 5, 2023, which brought Asaf Danziger around $23 Million.

Insider Trading History of Asaf Danziger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Asaf Danziger Trading Performance

GuruFocus tracks the stock performance after each of Asaf Danziger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Asaf Danziger is -24.82%. GuruFocus also compares Asaf Danziger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Asaf Danziger within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Asaf Danziger's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Asaf Danziger

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -12.63 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -16.05 LIMIT LIMIT LIMIT LIMIT LIMIT

Asaf Danziger Ownership Network

Ownership Network List of Asaf Danziger

No Data

Ownership Network Relation of Asaf Danziger

Insider Network Chart

Asaf Danziger Owned Company Details

What does NovoCure Ltd do?

Who are the key executives at NovoCure Ltd?

Asaf Danziger is the director & Chief Executive Officer of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Ashley Cordova , President & CNS Cancers US Frank X Leonard , and Chief Innovation Officer Uri Weinberg .

NovoCure Ltd (NVCR) Insider Trades Summary

Over the past 18 months, Asaf Danziger made no insider transaction in NovoCure Ltd (NVCR). Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 37,794 shares made by Frank X Leonard , a net sale of 1,982 shares made by , and a net sale of 29,729 shares made by Ashley Cordova .

In summary, during the past 3 months, insiders sold 79,948 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 79,948 shares. During the past 18 months, 97,906 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 97,906 shares.

NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovoCure Ltd Insider Transactions

No Available Data

Asaf Danziger Mailing Address

Above is the net worth, insider trading, and ownership report for Asaf Danziger. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Asaf Danziger's mailing address is: Tirat Hacarmel L3 5112302.